On March 29, according to relevant websites, Junshi Bio-PD-1 Teriplimumab's third indication (acceptance number: CXSS2000018
Both pictures and texts, teach you how to treat "hemorrhoids" under endoscopy (1)
Time of Update: 2021-04-14
It is only for medical professionals to read
Livzon's 1 billion varieties are super eye-catching, and the exclusive injection has increased by 600%!
Time of Update: 2021-04-14
Medical Network, March 31, News Livzon Group ushered in a bumper performance in 2020
Intriguing Phase 1: Anti-multidrug-resistant pulmonary tuberculosis treatment plan curative effect detection prediction
Time of Update: 2021-04-14
The intriguing and intriguing youth podcast
Kangfang Bio-PD-1 obtained FDA breakthrough therapy qualification, third-line treatment of metastatic nasopharyngeal carcinoma
Time of Update: 2021-04-14
In September 2020, Kangfang Bio announced that the registered clinical trial of Paimrizumab for the third-line
Huadong Medicine Class 1 biopharmaceutical IMGN853 was approved for clinical use
Time of Update: 2021-04-14
On March 30, the Sino-US East China Class 1 biopharmaceutical IMGN853 (Mirvetuximab Soravtansine), a subsidiary of East
The first domestic epothilone tumor drug may be born: a new breast cancer class 1 drug "under approval"
Time of Update: 2021-04-13
significant clinical benefits and safety advantages. >The specific research data are as follows: For patients with advanced breast cancer who have used anthracyclines and taxanes in the past, the overall survival
Health Commission: 12 newly diagnosed cases on the 26th, including 1 in the local area
Time of Update: 2021-04-13
-height: 30px"> Health Commission: 12 newly diagnosed cases on the 26th, including 1 in the local area
-
-
-
-
-
-
-
-
-
-
-
-
NEJM: Lumasiran, an interfering RNA for the treatment of primary type 1 hyperoxuria
Time of Update: 2021-04-13
>Primary type 1 hypergrassuria (PH1) is a rare genetic disease. Excessive hepatic oxalate secretion leads to kidney stones, nephrocalcinosis, renal failure, and systemic oxalic
FDA approves the first non-stimulant ADHD therapy in ten years, which is expected to benefit nearly 1 in 10 children
Time of Update: 2021-04-13
A few days ago, Supernus Pharmaceuticals announced that the US FDA has approved the company's Qelbree (viloxazine sustained-release capsules) to be marketed for the treatment of attention deficit hyperactivity disorder (ADHD) in pediatric patients aged 6-17.
Belarus plans to increase meat exports to 1 billion U.S. dollars in 2021
Time of Update: 2021-04-08
html" class="zdbq" title="Export-related food information" target="_blank">export of white meat products last year was US$973 million in 2021.
1 African swine fever outbreak occurred in South Africa on March 23, 2021
Time of Update: 2021-04-07
html" class="zdbq" title="Epidemic-related food information" target="_blank">epidemic Since 2021, there have been 440 domestic pigs and 1,884 wild boars in 14 countries and regions around the world, a total of 2,324 cases of African swine fever.
Construction of an epoxy circuit board plant with an investment of 1 billion yuan started
Time of Update: 2021-03-31
[China Epoxy Industry Online] October 11, 2005: Rizun, Japan Meiko Electronics (Wuhan) Co.
Xiao County was named "China's No. 1 Anti-corrosion County"
Time of Update: 2021-03-31
It is my country's second anti-corrosion regional brand after Changyuan County, Henan Province was named "China's National Defense Corrosion Capital".
stress pathway that enhances the response to PD-1 checkpoint blockade in prostate tumors
Time of Update: 2021-03-30
> >Prostate cancer occurs in prostate epithelial malignancies, is the male genitourinary
The first phase III study of Bristol-Myers Squibb PD-1+LAG-3 combination therapy is successful
Time of Update: 2021-03-29
RELATIVITY-047 study, a fixed-dose relatlimab (LAG-3 monoclonal antibody) + Opdivo (PD-1 monoclonal antibody) combination therapy for the first-line treatment of metastatic or unresectable melanin Compared with the use of Opdivo alone, tumors can
The market demand cannot hold up to 84 PD-1/L1 products, what will the latecomers survive?
Time of Update: 2021-03-29
Sales are a key factor in testing the commercialization capabilities of pharmaceutical companies, and the market prospects of domestically produced PD-1 monoclonal antibody varieties have been further clarified.
The smell of paint wafts from the underground garage of Shanghai No. 1 Residential Quarter: Hazardous substances exceed the standard by 20 times
Time of Update: 2021-03-29
According to the test report provided by the Shanghai Institute of Industrial Technology, in the underground garage and surrounding areas, the total volatile organic matter TVOC in the air exceeded the standard severely.
Industry | Xiangyang chemical companies cleared within 1 km along the Han River
Time of Update: 2021-03-28
In the next year, 13 chemical companies in Xiangyang City will complete their relocation and transformation work.
An explosion in a chemical plant in Huixian County, Henan Province killed 1 person
Time of Update: 2021-03-28
The cause of the accident is under further investigation.
After testing by the ecological environment department, the accident did not affect the surrounding environment.
Welcome to Echemi
